Show simple item record

dc.contributor.authorConcepción-Zavaleta, M.J.
dc.contributor.authorCoronado-Arroyo, J.C.
dc.contributor.authorQuiroz-Aldave, J.E.
dc.contributor.authorDurand-Vásquez, M.D.C.
dc.contributor.authorIldefonso-Najarro, S.P.
dc.contributor.authorRafael-Robles, L.D.P.
dc.contributor.authorConcepción-Urteaga, L.A.
dc.contributor.authorGamarra-Osorio, E.R.
dc.contributor.authorSuárez-Rojas, J.
dc.contributor.authorPaz-Ibarra, J.
dc.date.accessioned2025-10-31T18:44:56Z
dc.date.available2025-10-31T18:44:56Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.12805/6153
dc.description.abstractIntroduction: Infertility is defined as the inability to conceive after unprotected sexual intercourse for at least 12 consecutive months. Our objective is to present an updated narrative review on the endocrine causes of infertility in women. Areas covered: A comprehensive review was conducted using Scielo, Scopus, and EMBASE databases, comprising 245 articles. The pathophysiology of infertility in women was described, including endocrinopathies such as hypothalamic amenorrhea, hyperprolactinemia, polycystic ovary syndrome, primary ovarian insufficiency, obesity, thyroid dysfunction, and adrenal disorders. The diagnostic approach was outlined, emphasizing the necessity of hormonal studies and ovarian response assessments. Additionally, the treatment plan was presented, commencing with non-pharmacological interventions, encompassing the adoption of a Mediterranean diet, vitamin supplementation, moderate exercise, and maintaining a healthy weight. Subsequently, pharmacological treatment was discussed, focusing on the management of associated endocrine disorders and ovulatory dysfunction. Expert opinion: This comprehensive review highlights the impact of endocrine disorders on fertility in women, providing diagnostic and therapeutic algorithms. Despite remaining knowledge gaps that hinder more effective treatments, ongoing research and advancements show promise for improved fertility success rates within the next five years. Enhanced comprehension of the pathophysiology behind endocrine causes and the progress in genetic research will facilitate the delivery of personalized treatments, thus enhancing fertility rates.en_US
dc.description.sponsorshipThis paper was not funded.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherTaylor and Francis
dc.relation.ispartofurn:issn:1744-6651
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectMetabolic and Hormonal Dynamics in PCOS Managementen_US
dc.subjectObesity's Influence on Female Fertility Outcomesen_US
dc.titleEndocrine factors associated with infertility in women: an updated reviewen_US
dc.typehttps://purl.org/coar/resource_type/c_dcae04bc
dc.identifier.doihttps://doi.org/10.1080/17446651.2023.2256405
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.18
dc.type.otherReview
dc.identifier.journalExpert Review of Endocrinology and Metabolism
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2